Abstract:Objective: To perfect the theory system of minimally invasive treatment for osteonecrosis of the femoral head (ONFH) with β tricalcium phosphate (β-TCP) bioceramic system and evaluate the effectiveness. Methods: Eighteen New Zealand white rabbits aged 7-8 months were used to establish an animal model to verify the vascularization of porous β-TCP bioceramic rods. Micro-CT based three-dimensional reconstruction and fluorescence imaging were used to display the new blood vessels at 4, 8, and 12 weeks after operation. The inserting depth, number and diameter of vessels in the encapsulated area were analyzed. Nine pig femoral specimens were randomly divided into 3 groups ( n=3): group A was normal femur; group B had cavity (core decompression channel+spherical bone defect in femoral head); in group C, mixed bioceramic granules were implanted to fill the defect in femoral head, and porous β-TCP bioceramic rod was implanted into decompression channel. The stiffness and yield load of specimens were analyzed by biomechanical test. A multicenter retrospective study was conducted to analyze 200 patients (232 hips) with femoral head necrosis treated with bioceramic system in 7 hospitals in China between January 2012 and July 2018. There were 145 males and 55 females, with an average age of 42 years (range, 17-76 years). According to the Association Research Circulation Osseous (ARCO) stage, 150 hips were in stage Ⅱ and 82 hips in stage Ⅲ. Postoperative imaging assessment was carried out regularly, and hip function was evaluated by Harris score. The effectiveness of ARCO stage Ⅱ and Ⅲ was also compared. Results: Animal experiments showed that blood vessels could grow into the encapsulated area and penetrate it at 12 weeks. The inserting depth, number and diameter of blood vessels in the encapsulated area gradually increased, and there was significant difference between different time points ( P<0.05). Biomechanical tests showed that the stiffness and yield load of specimens in groups B and C were significantly lower than those in group A, while the yield load in group B were significantly lower than that in group C ( P<0.05). The stiffness in group C was restored to 41.52%±3.96% in group A, and the yield load was restored to 46.14%±7.85%. Clinical study showed that 200 patients were followed up 6-73 months, with an average of 22.7 months. At last follow-up, 12 patients (16 hips) underwent total hip arthroplasty, and the hip survival rate was 93.10%. According to the imaging evaluation, 184 hips (79.31%) were stable and 48 (20.69%) were worse. Harris score (79.3±17.3) was significantly higher than that before operation (57.3±12.0) ( t=18.600, P=0.000). The excellent rate of hip function was 64.22% (149/232). The survival rate of hip joint, imaging score and Harris score of patients in ARCO stage Ⅱ were better than those in ARCO stage Ⅲ ( P<0.05). Conclusion: β-TCP bioceramic system can guide the abundant blood supply of greater trochanter and femoral neck to the femoral head to promote repair; it can partly restore the mechanical properties of the femoral head and neck in the early stage, providing a new minimally invasive hip-preserving method for patients with ONFH, especially for those in early stage.

STUDY ON THE EFFECT OF ARTIFICIAL HIP JOINT REPLACEMENT ON BLOOD VESSEL CECs, EPCs AND SERUM OSTEOCALCIN OF PATIENTS WITH TRAUMATIC OSTEONECROSIS OF THE FEMORAL HEAD

Bayesian Network Meta-Analysis of the Effectiveness of Various Interventions for Nontraumatic Osteonecrosis of the Femoral Head

Curative effect of artificial femoral head replacement and its effect on hip joint function and complications of senile patients with femoral intertrochanteric fracture

Clinical study of artificial femoral head replacement and total hip arthroplasty in the treatment of 221 cases of femoral neck fracture with osteoporosis

Carbon-coated artificial femoral head replacement for unstable and osteoporotic femoral fractures in the elderly

THE EFFECT OF TWO KINDS OF TOTAL HIP ARTHROPLASTY FOR AVASCULAR NECROSIS OF THE FEMORAL HEAD IN 44 PATIENTS

An Analysis of the Effect of Artificial Lengthening Femoral Head Replacement in Elderly Patients with Stage Ⅰ of Unstable Femoral Intertrochanteric Fracture

Effect of Bone Protective Hormone on the Functional Recovery and the Level of Serum TRAP and CTX-Ⅱ of Patients with Steroid Induced Avascular Necrosis of the Femoral Head

The Clinical Study of Therapeutic Effect of Artificial Femoral HeadReplacement in the Treatment of Old Patients with IntertrochantericFemoral Fracture

Clinical efficacy analysis of artificial femoral head replacement in the treatment of femoral neck fracture in elderly patients

The clinical effect of treating osteonecrosis of the femoral head via bone impaction grafting

Quantitative Magnetic Resonance Imaging of Femoral Head Articular Cartilage Change in Patients with Hip Osteonecrosis Treated with Extracorporeal Shock Wave Therapy

Retrospective Long-Term Follow-Up Survival Analysis of the Management of Osteonecrosis of the Femoral Head With Pedicled Vascularized Iliac Bone Graft Transfer

Effect of Three Clinical Therapies on Cytokines Modulation in the Hip Articular Cartilage and Bone Improvement in Rat Early Osteonecrosis of the Femoral Head

A Study on the Effect and Mechanism of Core Decompression combined with Stem Cell Transplantation on Patients with Femoral Head Necrosis

Comparison of curative effect among the therapy of dynamic hip screws, proximal femoral nail and artificial femoral head replacement to treat unstable intertrochanteric fracture in elderly patient

Clinical Effects of Femoral Head Replacement for Unstable Intertrochanteric Fractures of the Fe-mur in the Elderly

[Minimally invasive treatment for osteonecrosis of the femoral head in ARCO stage Ⅱ and Ⅲ with bioceramic system]

Vascularised greater trochanter bone graft, combined free iliac flap and impaction bone grafting for osteonecrosis of the femoral head

Effects of Doctor-Nurse Integrated Care Combined with Health Education on Hip Function, Incidence of Deep Vein Thrombosis and Nursing Satisfaction in Patients with Hip Arthroplasty

Therapeutic Effect Evaluation of Artificial Hip Replacement